| Gilead Sciences, Inc. | 64.8500 / +1.63% |
| Date/Time | 11/15 / 18:32 |
| Chg. / Chg.(%) | 1.0400 / +1.63% |
| Bid | 64.8300 / 1000 |
| Ask | 64.8500 / 400 |
| Open | 64.1300 |
| Previous Close | 63.8100 |
| High | 65.2200 |
| Low | 64.0000 |
| Volume [USD] | 90,216,305.4706 |
| Volume [Units] | 2,872,559 |
| Price fixings | 14109 |
| ISIN | US3755581036 |
| Security | GILD |
| Exchange | NASDAQ |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 64.8500 |  |
2,872,559 |
| Cboe US | 64.84 | |
384,634 |
| IEX | 65.04 | |
152,523 |
| Xetra | 58.75 | |
6,655 |
| TradeGate | 58.820 | |
5,127 |
| London Inter.. | 64.85 | |
3,147 |
| Frankfurt | 58.7900 | |
1,074 |
| Borsa Italia.. | 58.88 | |
744 |
| Vienna Globa.. | 58.75 | |
504 |
| München | 58.80 | |
119 |
| Hamburg | 58.91 | |
100 |
| gettex | 58.790 | |
40 |
| Berlin | 57.98 |  |
0 |
| Hannover | 57.97 | |
0 |
| Düsseldorf | 57.78 | |
0 |
| Lang & Schwa.. | 58.660 | |
|
| Stuttgart | 58.840 | |
|
| Mexico | 1,215.00 |  |
334 |
| SIX Swiss Ex.. | 67.32 | ||
| SIX Swiss Ex.. | 60.00 | ||
| Borsa Italia.. | 57.09 |
News
- Nurix Therapeutics Announces Key Management Additions
11/14/2019 / 14:00 - GlobeNewswire - Transparency notification – Gilead holds 25.10% of Galapagos shares
11/13/2019 / 22:01 - GlobeNewswire - HOOKIPA Pharma Reports Third Quarter 2019 Financial Results and Provides a Corporate Update
11/12/2019 / 22:01 - GlobeNewswire - Cocrystal Pharma Presents Positive Data from U.S. Phase 2a Study of CC-31244 Demonstrating Ability to Identify Patients More Likely to Respond to Ultrashort Treatment of HCV
11/11/2019 / 14:35 - GlobeNewswire - NEW DATA ON FILGOTINIB IN RHEUMATOID ARTHRITIS (RA) DEMONSTRATE DURABLE EFFICACY AND SAFETY PROFILE
11/09/2019 / 22:30 - GlobeNewswire
Real-time